ORKA

Funicular Fund, LP

CIK: 0001752618

Funicular Fund, LP's purchase track record

How the stock did after each of Funicular Fund, LP's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
6
of 6 since April 4, 2022
Stock higher 6 months later
0%
3 months: 83%
Median 6-month return
-11.9%
3 months: +3.9%
Beat the S&P 500
50%
median -1.2% vs. index
PurchaseStockAmount3 months6 months
5/23/2022ORKA$197K+1.3%-10.8%
5/13/2022ORKA$161K+6.9%-13.0%
5/5/2022ORKA$450K+1.8%-8.8%
4/25/2022ORKA$109K-2.1%-15.6%
4/12/2022ORKA$223K+6.0%-14.5%
4/4/2022ORKA$598K+7.3%-10.7%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

HC Wainwright Reiterates $120 Target on Oruka. HC Wainwright maintained its buy rating on Oruka Therapeutics, keeping its price target at $120. The firm continues to see the company favorably despite recent trading levels well below that target. The analyst consensus average for the stock stands at $153.75, with estimates ranging from $102 to $200.

this person other insiders at ORKA

Transaction History

ORKA▲ Buy$151K
ORKA▲ Buy$41K
ORKA▲ Buy$5K
ORKA▲ Buy$2
ORKA▲ Buy$30K
ORKA▲ Buy$99K
ORKA▲ Buy$32K
ORKA▲ Buy$63K
ORKA▲ Buy$56K
ORKA▲ Buy$48K
ORKA▲ Buy$112K
ORKA▲ Buy$132K
ORKA▲ Buy$38K
ORKA▲ Buy$3K
ORKA▲ Buy$21K
ORKA▲ Buy$54K
ORKA▲ Buy$32K
ORKA▲ Buy$21K
ORKA▲ Buy$41K
ORKA▲ Buy$161K
ORKA▲ Buy$11K
ORKA▲ Buy$71K
ORKA▲ Buy$64K
ORKA▲ Buy$62K
ORKA▲ Buy$114K
ORKA▲ Buy$276K

We use analytics to understand how market-wall is used. No personal data is sold.